<DOC>
	<DOCNO>NCT00657930</DOCNO>
	<brief_summary>This study conduct Europe . The aim observational study gain practical experience once-daily Levemir administration type 2 diabetes patient previously treat Insulatard® , Humulin® N ( NPH insulins ) basal insulin part ICT normal clinical practice condition Hungary .</brief_summary>
	<brief_title>Observational Study Type 2 Diabetes Treated Intensive Insulin Treatment ( ICT ) Containing Once Daily Levemir® ( Insulin Detemir )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Type 2 diabetic subject intensive insulin treatment ( ICT ) Eligibility daily insulin detemir administration Informed consent obtain observationrelated activity Known suspect allergy insulin detemir Subjects previously enrol observation Women pregnant , breast feeding intention become pregnant within 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>